Starpharma DEP® docetaxel and gemcitabine combination trial commences
4 August 2020 Release date 30 July 2020 Starpharma today announced that it has commenced its DEP® docetaxel + gemcitabine combination study for patients with advanced cancers, including pancreatic cancer. Recruitment into the study has commenced at the…
Cynata Completes Phase 1 GvHD Clinical Trial Follow-up with Positive Results
4 August 2020 Release date 30 July 2020 Cynata Therapeutics Limited, a clinical-stage biotechnology company specialising in cell therapeutics, has today announced positive results from the two-year follow-up of patients enrolled in the Phase 1 clinical trial of…
Medical research grant recipients announced, including COVID-19 research fund grants
4 August 2020 The Victorian Government is backing cutting-edge medical research projects to better understand, prevent and treat coronavirus. Seven projects will benefit from the government’s $5.5 million COVID-19 Research Fund, which will support continued jobs growth in a sector…
EY 2020 Australian Insurtech Report: Partnering to Deliver Value at Scale
4 August 2020 The EY 2020 Australian insurtech ecosystem report shows insurtechs, insurers and service providers agree that the industry is driving value through insurtech, but there are several areas ripe for innovation. EY’s previous two reports found…
Stem cell project aims to better understand impact of COVID-19 on different organs
4 August 2020 Release date 30 July 2020 Researchers at the Murdoch Children’s Research Institute (MCRI), with other Melbourne-based partners, will use human stem cells to better understand the effects of COVID-19 on different organs after being…
Navi Medical Technologies Secure City of Melbourne Small Business Grant
30 July 2020 The City of Melbourne has helped hundreds of innovators and entrepreneurs start up or expand their businesses since 1996. They have also encouraged dozens of businesses to enter overseas markets and supported member-based organisations to…
Dimerix’s DMX-200 posts strong results in kidney disease trial
29 July 2020 Melbourne-based, clinical-stage biopharmaceutical company Dimerix has reported excellent results from the clinical trial of its drug candidate DMX-200, which is aimed at a rare kidney disease called focal segmental glomerulosclerosis, or FSGS. FSGS is caused…
Discovery of a rare human gene mutation that causes MAIT cells to disappear
30 July 2020 A collaboration between Monash Health, the Australian Genomics Health Alliance (AGHA) and researchers at the Monash Biomedicine Discovery Institute has led to the discovery of a rare single gene mutation in a patient that eliminates…
Hemideina Awarded Grant To Fast Track Miniature, Low-Energy, Wireless Power And Data Transmission System For Wireless Cochlear Implant
30 July 2020 Hemideina, a hearing technology company enabling people with sensorineural hearing loss to enjoy a world of sound and to live life without limits, announced today that it was awarded a $660,000 BioMedTech Horizons (BMTH) Grant,…
Nucleus Network welcomes new Associate Medical Director and Principal Investigator
28 July 2020 Nucleus Network is pleased to welcome Dr Robyn Langham to the team as Associate Medical Director and Principal Investigator. Robyn brings a wealth of knowledge with over 20 years of experience as a medical researcher…
IBX raises $5M in oversubscribed placement
29 July 2020 Highlights $5M raised in an oversubscribed placement at 4.5c per share – equivalent to 30 day VWAP, and a 33.9% premium to 60 day VWAP. Strongly supported by existing domestic institutional investors and sophisticated…
La Trobe passes net zero solar milestone
27 July 2020 La Trobe University is destined to achieve net zero carbon emissions by 2029 with the completion of an ambitious solar energy project at its Bundoora Campus. The University has today energised 7500 solar panels on…
